story of the week
Immune Responses Following SARS-CoV-2 mRNA Vaccination in MS Patients on Anti-CD20 Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Nature Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy
Nat. Med. 2021 Sep 14;[EPub Ahead of Print], SA Apostolidis, M Kakara, MM Painter, RR Goel, D Mathew, K Lenzi, A Rezk, KR Patterson, DA Espinoza, JC Kadri, DM Markowitz, C E Markowitz, I Mexhitaj, D Jacobs, A Babb, MR Betts, ETL Prak, D Weiskopf, A Grifoni, KA Lundgreen, S Gouma, A Sette, P Bates, SE Hensley, AR Greenplate, EJ Wherry, R Li, A Bar-OrFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.